Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Orbital immunoblastosarcoma (author's transl)]

P Dhermy, J Diebold, M Reynes

    Journal Francais D'Ophtalmologie
    |February 20, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase I Clinical Study of DOC1021 (dubodencel) for Adjuvant Immunotherapy of Glioblastoma.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Observations on Utero-Gestation, with Suggestions How to Arrive at More Correct Data in Respect to the Time Occupied.

    Medical examiner (Philadelphia, Pa.)·2023
    Same author

    Latest results show urgent need to address child restraint use.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2019
    Same author

    The utility of monitoring trimellitic anhydride (TMA)-specific IgG to predict IgE-mediated sensitization in an immunosurveillance program.

    Allergy·2017
    Same author

    [Rhabdomyosarcomas of the orbit].

    Archives d'ophtalmologie et revue generale d'ophtalmologie·2014
    Same author

    The surface area of the hand and the palm for estimating percentage of total body surface area: results of a meta-analysis.

    The British journal of dermatology·2013
    Same journal

    Silent threat to sight after bariatric surgery: Vision loss from vitamin A deficiency.

    Journal francais d'ophtalmologie·2026
    Same journal

    Persistent subretinal fluid and subretinal precipitates following pneumatic retinopexy.

    Journal francais d'ophtalmologie·2026
    Same journal

    Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

    Journal francais d'ophtalmologie·2026
    Same journal

    Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

    Journal francais d'ophtalmologie·2026
    Same journal

    Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

    Journal francais d'ophtalmologie·2026
    Same journal

    [Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

    Journal francais d'ophtalmologie·2026
    See all related articles

    Immunoblastosarcoma, a specific lymphoid tumor, is increasingly recognized in orbital tissues. Despite treatments, this tumor type has a poor prognosis, highlighting the need for further research.

    Area of Science:

    • Oncology
    • Ophthalmology
    • Pathology

    Background:

    • Recent lymphoid tumor classifications incorporate immunoblastosarcoma.
    • Immunoblastosarcoma was previously often misclassified within obsolete reticulosarcoma categories.
    • The reticular cell's poorly defined characteristics led to the obsolescence of reticulosarcoma classification.

    Observation:

    • Two orbital cases of immunoblastosarcoma are reported.
    • This tumor exhibits distinct clinical and histological features.
    • Immunoblasts are the cell of origin for this tumor type.

    Findings:

    • Immunoblastosarcoma is a distinct entity within lymphoid neoplasms.
    • The cytological and histological traits of immunoblasts are detailed.
    • Orbital immunoblastosarcoma presents specific characteristics justifying its separate classification.

    Related Experiment Videos

    Implications:

    • The recognition of immunoblastosarcoma aids in accurate tumor classification.
    • Understanding its specific characteristics is crucial for diagnosis and treatment.
    • The poor prognosis underscores the need for improved therapeutic strategies for orbital immunoblastosarcoma.